Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05277688 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Dec 30, 2025 → Dec 30, 2027
See other at-risk trials from Ruijin Hospital

Record History

  1. Primary completion pushed from Dec 30, 2025 to Dec 30, 2027v3
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 1 to 2v2 Show 1 more changeShow less
    • Study sites: 1 to 2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate if adjuvant concurrent chemoradiotherapy is associated with a recurrence-free survival benefit in comparison with radiotherapy alone in selected intermediate risk cervical cancer after radical surgery.
Trial Details
NCT Number NCT05277688
Lead Sponsor Ruijin Hospital
Conditions Cervical Cancer
Enrollment 340 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov